"We bring solutions to life. We are a clinically-focused medical research organization that accelerates the launch of new drug therapies and devices currently in the testing stages of development. Since 2003, our team of researchers and partners has committed themselves every day to the science of health. Today, we continue that dedication through our collaboration with the pharmaceutical and biotechnical community to uncover new treatments that save lives and enhance or improve quality of life. We brave new frontiers to advance scientific discovery and medical knowledge by combining human touch and scientific rigor to create moments that change lives, one clinical trial at a time."

During the past decade, Pensacola Research Consultants conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pensacola Research Consultants" #1 sponsor was "Pfizer" with 3 trials, followed by "ByHeart" with 2 trials sponsored, "CVRx, Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pensacola Research Consultants" #1 collaborator was "Norgine" with 2 trials as a collaborator, "Paidion Research, Inc." with 2 trials as a collaborator, "Cystic Fibrosis Foundation" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pensacola Research Consultants" are "Gastrointestinal Dysmotility" (2 trials), "Heart Failure" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Influenza" (2 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Pensacola Research Consultants" in a lesser frequency.

Most popular intervention types in "Pensacola Research Consultants" are "Drug" (20 trials), "Biological" (4 trials), "Other" (4 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "5% dextrose in water" (2 trials), "Baloxavir Marboxil" (2 trials), "Comparator Formula (CF)" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pensacola Research Consultants" are 27 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pensacola Research Consultants". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Pensacola Research Consultants, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pensacola Research Consultants, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".